数据驱动的代谢亚型预测1型糖尿病个体未来不良事件
该研究基于FinnDiane队列中2059名男性和1924名女性1型糖尿病患者,按2008年发表的六种代谢亚型进行分组,分析新临床终点并与全国登记数据比较。结果显示晚期肾病亚型与最高的肾病进展、缺血性心脏病和全因死亡率相关,代谢综合征亚型预测心血管死亡,高HDL胆固醇亚型女性心血管风险高。
要点
- 晚期肾病亚型与最高的肾病进展、缺血性心脏病和全因死亡率相关。
- 代谢综合征亚型预测心血管死亡,高HDL胆固醇亚型女性心血管风险高。
- 低胆固醇或良好血糖控制亚型男性无超额死亡率。
核心结论
- 数据驱动的多变量代谢亚型同时预测了多个临床终点的并发症负担差异。
- 代谢综合征男性和高HDL胆固醇女性应被视为1型糖尿病干预研究和公共卫生指南中的重要亚组。
研究设计与样本
- 芬兰1型糖尿病个体(2059名男性、1924名女性,35岁前接受胰岛素治疗)由全国多中心FinnDiane研究组招募。
- 参与者根据2008年先前发表的自我组织映射图被分配至六种代谢亚型之一。
- 将FinnDiane队列中亚型特异性全因和心血管死亡率与芬兰全国人口登记数据进行比较。
- 基于医院记录估计新发糖尿病肾病和心血管终点的发生率。
主要发现
- 晚期肾病亚型与最高的肾病进展发生率(每十年67.5%,p < 0.001)、缺血性心脏病(每十年26.4%,p < 0.001)和全因死亡率(每十年41.5%,p < 0.001)相关。
- 所有亚型中女性死亡率低于男性,但女性标准化死亡比(SMR)更高。
- 原始研究期间(1994-2007)和新期间(2008-2014)的SMR无法区分。
- 代谢综合征亚型预测心血管死亡(男性SMR 11.0,女性SMR 23.4,p < 0.001),高HDL胆固醇亚型女性心血管风险也高(SMR 16.3,p < 0.001)。
- 低胆固醇或良好血糖控制亚型男性未显示超额死亡率。
关键数值与推荐
- 晚期肾病亚型:肾病进展每十年67.5%(p < 0.001),缺血性心脏病每十年26.4%(p < 0.001),全因死亡率每十年41.5%(p < 0.001)。
- 代谢综合征亚型:心血管死亡男性SMR 11.0,女性SMR 23.4(p < 0.001)。
- 高HDL胆固醇亚型女性:心血管死亡SMR 16.3(p < 0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Previously, we proposed that data-driven metabolic subtypes predict mortality in type 1 diabetes. Here, we analysed new clinical endpoints and revisited the subtypes after 7 years of additional follow-up. METHODS: Finnish individuals with type 1 diabetes (2059 men and 1924 women, insulin treatment before 35 years of age) were recruited by the national multicentre FinnDiane Study Group. The participants were assigned one of six metabolic subtypes according to a previously published self-organising map from 2008. Subtype-specific all-cause and cardiovascular mortality rates in the FinnDiane cohort were compared with registry data from the entire Finnish population. The rates of incident diabetic kidney disease and cardiovascular endpoints were estimated based on hospital records. RESULTS: The advanced kidney disease subtype was associated with the highest incidence of kidney disease progression (67.5% per decade, p < 0.001), ischaemic heart disease (26.4% per decade, p < 0.001) and all-cause mortality (41.5% per decade, p < 0.001). Across all subtypes, mortality rates were lower in women compared with men, but standardised mortality ratios (SMRs) were higher in women. SMRs were indistinguishable between the original study period (1994-2007) and the new period (2008-2014). The metabolic syndrome subtype predicted cardiovascular deaths (SMR 11.0 for men, SMR 23.4 for women, p < 0.001), and women with the high HDL-cholesterol subtype were also at high cardiovascular risk (SMR 16.3, p < 0.001). Men with the low-cholesterol or good glycaemic control subtype showed no excess mortality. CONCLUSIONS/INTERPRETATION: Data-driven multivariable metabolic subtypes predicted the divergence of complication burden across multiple clinical endpoints simultaneously. In particular, men with the metabolic syndrome and women with high HDL-cholesterol should be recognised as important subgroups in interventional studies and public health guidelines on type 1 diabetes.
引用
- Lithovius R, Toppila I, Harjutsalo V, et al. Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes. Diabetologia. 2017. PMID: 28439641. doi:10.1007/s00125-017-4273-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。